Daubeuf, François
75  results:
Search for persons X
?
1

Targeted Anticancer Agent with Original Mode of Action Prep..:

Lehot, Victor ; Neuberg, Patrick ; Ripoll, Manon...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15061643.  , 2023
 
?
 
?
3

Targeted Anticancer Agent with Original Mode of Action Prep..:

Lehot, Victor ; Neuberg, Patrick ; Ripoll, Manon...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15061643.  , 2023
 
?
4

Targeted Anticancer Agent with Original Mode of Action Prep..:

Lehot, Victor ; Neuberg, Patrick ; Ripoll, Manon...
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15061643.  , 2023
 
?
6

Context-dependent function of TSLP and IL-1β in skin allerg..:

Segaud, Justine ; Yao, Wenjin ; Marschall, Pierre...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-022-32196-1.  , 2022
 
?
7

A Novel Family of Acid-Cleavable Linker Based on Cyclic Ace..:

Rady, Tony ; Turelli, Lorenzo ; Nothisen, Marc...
info:eu-repo/semantics/altIdentifier/doi/10.1021/acs.bioconjchem.2c00314.  , 2022
 
?
8

A Novel Family of Acid-Cleavable Linker Based on Cyclic Ace..:

Rady, Tony ; Turelli, Lorenzo ; Nothisen, Marc...
info:eu-repo/semantics/altIdentifier/doi/10.1021/acs.bioconjchem.2c00314.  , 2022
 
?
9

Context-dependent function of TSLP and IL-1β in skin allerg..:

Segaud, Justine ; Yao, Wenjin ; Marschall, Pierre...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-022-32196-1.  , 2022
 
?
10

A Selective Neutraligand for CXCL12/SDF-1α With Beneficial ..:

Schall, Nicolas ; Daubeuf, Francois ; Marsol, Claire...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fphar.2021.752194.  , 2021
 
?
11

Design, Synthesis and Biological Evaluation of Arylpyridin-..:

Bollenbach, Maud ; Nemska, Simona ; Wagner, Patrick...
info:eu-repo/semantics/altIdentifier/doi/10.3390/molecules26020391.  , 2021
 
?
12

A Selective Neutraligand for CXCL12/SDF-1α With Beneficial ..:

Schall, Nicolas ; Daubeuf, Francois ; Marsol, Claire...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fphar.2021.752194.  , 2021
 
1-15